The field of use
of the drug Mexidol®
The use of Mexidol® is effective in therapy of acute and chronic cerebrovascular diseases caused by ischemia and hypoxia of various genesis. To date, the drug is one of the main products of basic neuroprotective brain therapy due to the multimodal mechanism of action, which provides a wide range of pharmacological effects. Mexidol® is successfully used in various fields of medicine: neurology, therapy, ophthalmology, cardiology, neuropediatry, psychiatry and narcology.
<a i=0>Acute</a> <a i=1>cerebrovascular disorders</a>
Stroke is an acute cerebrovascular impairment, causing damage and the death of nerve cells. The stroke is characterized by sudden (within a few minutes, hours) by the appearance of focal and/or common neurological symptoms, which persists for more than 24 hours or leads to the death of the patient in a shorter period of time due to cerebrovascular pathology. The use of Mexidol® in the acute period of ischemic stroke at the prehospital stage, followed by thrombolytic therapy, has a positive effect on a decrease in neurological deficiency, regardless of the severity of the disease. Mexidol® confirmed its effectiveness and safety in numerous studies. The study of Epic proved a decrease in the severity of neurological deficiency and an improvement in the quality of life of patients when using the drug Mexidol® in the complex therapy of ischemic stroke in the acute and early recovery periods.
Chronic
brain ischemia
Chronic brain ischemia is a slowly progressive structural and functional change in the brain. Such a change occurs due to diffuse and/or small cudbow damage to the brain tissue in conditions of long -existing insufficiency of cerebral blood supply. An important component of the treatment of chronic brain ischemia is the prescription of drugs with multimodal effects with antioxidant, anti -hyphyxant and neuroprotective activity.
A bright representative of multimodal neuroprotectors is Mexidol® (original ethylmethylhydroxypyridine succinate). The drug showed a high degree of efficiency and safety in an international multicenter randomized double blind, a placebo-controlled study of patients with chronic brain ischemia (memo study).
Cognitive disorders
against the background of arterial hypertension
Cognitive disorders are different in the degree of severity of violations of higher mental functions. Such functions include: memory, attention, gnosis, praxis, speech, social intelligence and control functions. As a result of pathological processes in the tissues of the brain, impaired violations affect these functions. Often, cerebral symptoms cause patients to see the doctor and the beginning of treatment of arterial hypertension (AH). First of all, patients with AH are complaining of headache, dizziness, deterioration, forgetfulness, general weakness. This is due to the fact that one of the main target organs in hypertension is the brain. The use of Mexidol® in the treatment of cognitive disorders in patients with cerebrovascular diseases, such as chronic brain ischemia (chemical) with concomitant arterial hypertension, showed high efficiency and safety.
Attention deficit syndrome
in children
Syndrome of attention deficit and hyperactivity in children. Focus and hyperactivity deficiency syndrome* (ADHD) - a disorder of the nervous system that affects the behavior, concentration and teaching of children. Children with ADHD are inattention, high distracting, excessive motor activity, impulsive behavior, and communication problems. Treatment of ADHD should include a set of measures that take into account the individual characteristics of the child. The key cause of the disease, the links of pathogenesis, clinical manifestations, the presence of comorbid diseases should be taken into account. Mexidol® is a modern neurometabolic drug that proved its effectiveness in the treatment of ADHD. The drug has a good safety profile, which is proved in the mega study. In this regard, the use of Mexol® is common in pediatric practice.
* For ADHD, Mexidol tablets covered with a film membrane are used, 125 mg.
THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.
Source of photos and images Shutterstock.com